🔎 Trials Near Me

Akèy › Maladi otoim › Kalifòni › Orange

Etid klinik pou Maladi otoim nan Orange, CA

7 etid pou Maladi otoim ap chèche patisipan nan sit nan ak bò kote Orange (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy

Ap rekriteFaz 2/3
  • University of California Irvine - Accepting Adult Patients, Orange
Laj 6 a 75 · Tout sèks · Mizajou Sep 17, 2026 · NCT06154252

A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease

Ap rekriteFaz 3
  • GSK Investigational Site, Orange
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT06572384

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

Ap rekriteFaz 1/2
  • University of California Irvine, Orange
Laj 18 a 65 · Tout sèks · Mizajou Aug 26, 2026 · NCT06121297

RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis

Ap rekriteFaz 1/2
  • University of California Irvine, Orange
Laj 18 a 70 · Tout sèks · Mizajou Aug 13, 2026 · NCT06359041

KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis

Ap rekriteFaz 2/3
  • University of California, Irvine, Orange
Laj 18 a 75 · Tout sèks · Mizajou Jul 29, 2026 · NCT06193889

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Ap rekriteEtid obsèvasyon
  • Children's Hospital of Orange County (CHOC), Orange
Tout laj · Tout sèks · Mizajou Jul 6, 2026 · NCT01351545

A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases

Ap rekriteFaz 1
  • University of California, Irvine, Orange
Laj 18 ak plis · Tout sèks · Mizajou Feb 25, 2026 · NCT06626919

Etid Maladi otoim nan lòt vil

Lòt etid nan Orange

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.